The Thread Formerly Known as No Rest For The Wicked Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jane4IceCream who wrote (38440)	5/11/1999 11:02:00 AM
From: JeffA	Read Replies (1) of 90042

JJJ This is from earlier this morning. BEFORE THE BELL - Immunex surges NEW YORK, May 11 (Reuters) - Shares of Immunex Corp. rose in pre-opening trade Tuesday after the drug company said it would seek approval for expanded use of an arthritis drug. Immunex was at 130 on the Instinet electronic broker system, up from a Monday close at 107. The rise came after the company said it planned to seek regulatory approval for wider use of its drug Enbrel in patients with early, active rheumatoid arthritis. Among other active issues, America Online Inc. (AOL - news) rose to 134-3/4 after the Web service provider said it had entered four partnerships to develop its AOL TV product.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next